企業プロフィール

Novan 株価・ニュース・カタリスト

ティッカー:
NOVN
取引所:
NASDAQ
セクター:
Biopharma
所在地:
United States

株価変動の要因

Current closing-price context is not available for NOVN.

企業概要

事業概要

Novan was a dermatology-focused biotechnology company built around nitric oxide-based therapies for skin conditions and related inflammatory indications. Its story was centered on a narrow clinical platform and the challenge of turning topical science into a durable commercial path.

所在地とセクター分類

Novan was headquartered in the United States and listed on NASDAQ, with a profile tied to dermatology and specialty biotech. It belonged to the small-cap development universe rather than a diversified pharma category.

ビジネスモデルの特徴

The business depended on clinical progress, regulatory milestones, and financing discipline more than on broad commercial diversification. Investors typically watched proof-of-concept data, development updates, and whether the company could advance a focused dermatology franchise.

バイオ業界での位置付け

Novan occupied a legacy small-cap dermatology niche within biotech. Because it was highly dependent on a limited number of programs, the stock was always sensitive to execution, funding, and regulatory visibility.

今後のカタリスト

  • Novan is also mostly a legacy / closeout story, with catalysts limited to any residual asset or corporate-resolution update. There is no active standalone growth story left.

最近のニュース

  1. 01
  2. 02
  3. 03
  4. 04
  5. 05

類似銘柄

事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。